NISHA GOKHALE: Open Payments
NPI 1679913768 · OAK LAWN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 29 payments from 11 companies in 2025. Trend: 2023 $1,098 · 2024 $976 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $178 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Lundbeck LLC | 2 | $36 |
| Almatica Pharma LLC | 1 | $30 |
| Indivior Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
Products named: INGREZZA, CAPLYTA, REXULTI, ABILIFY ASIMTUFII, COBENFY, LOREEV XR, SUBLOCADE, LYBALVI.
Industry payments across IL — which companies pay providers there.
